ProPhase Labs Inc (PRPH)

ProPhase Labs Inc (PRPH) is a Diagnostics & Research company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $155,925; returns 1 day -3.2%, 1 year -99.7%.

ProPhase Labs Inc is a diversified biotechnology and genomics company that has pivoted from its pandemic-era COVID-19 testing volume to a model focused on high-growth molecular diagnostics and personalized medicine.

Groups PRPH belongs to

• Biotechnology
• Recent Reverse Splits
• Healthcare
• Life Sciences
• Personalized Medicine
• Early Cancer Detection
• Health Diagnostics and Imaging
• Oncology
• Life Sciences Tools & Services
• Consumer Products
• Dietary Supplements

PRPH financial model: income statement, cash flow and balance sheet